title: [Is there a correlation between C-reactive protein and calcification inhibitors with cardiovascular parameters and risk factors in hemodialysis patients?].
abstract: OBJECTIVE
  Patients on hemodialysis exhibit a drastically increased cardiovascular mortality. Inflammation, hyperphosphatemia and lack of calcification inhibitors are uremia-associated risk factors for vascular calcification. Functional and morphological vascular parameters are used to assess cardiovascular risk. The aim of our study was to analyse the relation between pulse wave velocity (PWV) and intima-media-thickness (IMT) with calcification inhibitors.
  
  
  METHODS
  A cohort of 97 hemodialysis patients was consecutively selected and investigated (age 56 +/- 9 years). Carotid-femoral PWV, carotid IMT, left ventricular ejection fraction and septum thickness were determined. These parameters were correlated with serum levels of CRP and calcification inhibitors (fetuin-A and osteoprotegerin [OPG]).
  
  
  RESULTS
  Both PWV and IMT showed a positive correlation with age and systolic blood pressure and a negative correlation with Kt/V (dialysis efficiency). Additionally, fetuin-A was negatively associated with CRP and positively with cholesterol and triglycerides. Serum levels of the calcification inhibitors fetuin-A and OPG were not correlated to PWV or IMT.
  
  
  CONCLUSIONS
  The lack of correlation of calcification inhibitors with PWV and IMT means that functional and morphological measurements of vascular properties can not necessarily be replaced by analysing "biomarkers".
authors.affiliation: Medizinische Klinik II, Nephrologie und Klinische Immunologie, Universitätsklinikum Aachen, Germany. gschlieper@ukaachen.de
authors.forename: G
authors.initials: G
authors.lastname: Schlieper
authors.forename: V
authors.initials: V
authors.lastname: Brandenburg
authors.forename: Z
authors.initials: Z
authors.lastname: Djuric
authors.forename: T
authors.initials: T
authors.lastname: Damjanovic
authors.forename: N
authors.initials: N
authors.lastname: Markovic
authors.forename: R
authors.initials: R
authors.lastname: Westenfeld
authors.forename: N
authors.initials: N
authors.lastname: Dimkovic
authors.forename: M
authors.initials: M
authors.lastname: Ketteler
authors.forename: J
authors.initials: J
authors.lastname: Floege
mesh_terms: D000375:Aging / Q000473:pathology; D001161:Arteriosclerosis / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology; D001794:Blood Pressure; D001798:Blood Proteins / Q000032:analysis*; D002097:C-Reactive Protein / Q000032:analysis*; D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000209:etiology* / Q000401:mortality; D002784:Cholesterol / Q000097:blood; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D053244:Osteoprotegerin / Q000097:blood*; D011674:Pulse; D006435:Renal Dialysis / Q000009:adverse effects; D014280:Triglycerides / Q000097:blood; D017539:Tunica Intima / Q000473:pathology; D017540:Tunica Media / Q000473:pathology; D060749:alpha-2-HS-Glycoprotein
chemical_list: C556354:AHSG protein, human; D001798:Blood Proteins; D053244:Osteoprotegerin; D014280:Triglycerides; D060749:alpha-2-HS-Glycoprotein; D002097:C-Reactive Protein; D002784:Cholesterol